Premium
Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin
Author(s) -
Cassaday Ryan D.,
Marks David I.,
DeAngelo Daniel J.,
Jabbour Elias J.,
Advani Anjali S.,
O’Brien Susan,
Wang Tao,
Neuhof Alexander,
Vandendries Erik,
Kantarjian Hagop M.,
Stock Wendy,
Stelljes Matthias
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17029
Subject(s) - refractory (planetary science) , medicine , pediatrics , calicheamicin , oncology , physics , astrobiology , myeloid leukemia